ÖZKAN, T. Et Al. 2021. Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. Leukemia Research , vol.102 .

ÖZKAN, T., Hekmatshoar, Y., KARABAY, A. Z., KOÇ, A., ALTINOK GÜNEŞ, B., KARADAĞ GÜREL, A., ... SUNGUROĞLU, A.(2021). Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells. Leukemia Research , vol.102.

ÖZKAN, TÜLİN Et Al. "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells," Leukemia Research , vol.102, 2021

ÖZKAN, TÜLİN Et Al. "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells." Leukemia Research , vol.102, 2021

ÖZKAN, T. Et Al. (2021) . "Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells." Leukemia Research , vol.102.

@article{article, author={TÜLİN ÖZKAN Et Al. }, title={Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cells}, journal={Leukemia Research}, year=2021}